Serum Interleukin-33 is a Novel Predictive Biomarker of Hemorrhage Transformation and Outcome in Acute Ischemic Stroke
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (2) , 105506
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Blood–brain barrier permeability derangements in posterior circulation ischemic stroke: Frequency and relation to hemorrhagic transformationJournal of the Neurological Sciences, 2012
- The IL-33/ST2 pathway — A new therapeutic target in cardiovascular diseasePharmacology & Therapeutics, 2011
- Chronic Systemic Infection Exacerbates Ischemic Brain Damage via a CCL5 (Regulated on Activation, Normal T-Cell Expressed and Secreted)-Mediated Proinflammatory Response in MiceJournal of Neuroscience, 2010
- Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical OutcomeStroke, 2008
- Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cellsCytokine, 2007
- IL‐33 is a chemoattractant for human Th2 cellsEuropean Journal of Immunology, 2007
- Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparisonEuropean Journal of Neurology, 2006
- Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cellsMolecular and Cellular Neuroscience, 2006
- Expression of ST2, an Interleukin-1 Receptor Homologue, Is Induced by Proinflammatory StimuliBiochemical and Biophysical Research Communications, 1997
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1989